Riskpilot← Back to searchSign inGet full accessRINGEN APOTEK HOLDING AS
ASActiveOrg 911645254Lysåsstubben 2D, 2052 JessheimRetail sale of pharmaceutical products · NACE 4773Est. 20130 employees
Revenue 2024
NOK 0
EBITDA margin
—
-10% vs 2023
Equity ratio
31.7%
Financial strength
Net profit 2024
NOK 700K
+90% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -48K | -10% |
| Net profit | NOK 700K | +90% |
| Total assets | NOK 1,5M | +190% |
| Equity | NOK 477K | +0% |
| Employees | 0 | — |
Legal name
RINGEN APOTEK HOLDING AS
Org number
911645254
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
11. mars 2013
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Eie aksjer og andeler i andre selskaper og sammenslutninger samt andre aktiviteter i naturlig sammenheng med dette.
Address
Lysåsstubben 2D, 2052 Jessheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −36 | −26 | −37 | −43 | −48 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −36 | −26 | −37 | −43 | −48 |
| Net financials | 414 | 1 400 | 670 | 426 | 748 |
| Profit before tax | 378 | 1 375 | 633 | 382 | 700 |
| Tax | 17 | −6 | −8 | 14 | −0 |
| Net profit | 361 | 1 380 | 641 | 369 | 700 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 776 | 1 688 | 935 | 520 | 1 506 |
| Equity | 157 | 1 437 | 108 | 477 | 477 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 619 | 251 | 827 | 43 | 1 029 |
| Total debt | 619 | 251 | 827 | 43 | 1 029 |
EBITDA margin
-4787200.0%
This company
15.8%
Market median
-30298834% vs market
20202024
Equity ratio
31.7%
This company
38.2%
Market median
+17% vs market
20202024
Return on equity
146.8%
This company
18.4%
Market median
+698% vs market
20202024
Net profit margin
70000000.0%
This company
8.1%
Market median
+864197431% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.16×
This company
0.62×
Market median
-248% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BK Chief Executive Officer | Chief Executive Officer | 2013 |
| Former (1) | ||
BH Chief Executive Officer | Chief Executive Officer | 2013 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
RINGEN APOTEK HOLDING AS (this company)
RINGEN APOTEK RÆLINGEN ASBoard members of RINGEN APOTEK HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Beryll Hanne Kristensen | Chief Executive Officer | 0 companies |
| Beryll Kristensen Konarboland | Chief Executive Officer | 0 companies |
| Roozbeh Konarboland | Chairman | 0 companies |